Alnylam receives expected FDA ok for Onpattro Biotech trust stock favourite Alnylam Pharmaceuticals (Nasdaq: ALNY) received its first FDA approval late on Friday for Onpattro (patisiran) for the treatment of polyneuropathy in adults with hereditary transthyretin-mediated (hATTR) amyloidosis. However, the FDA did not allow a broader label that included patients with cardiomyopathy (CM), leading to […]
BG-backed Orchard raises $150m on the back of GSK deal Baillie Gifford-backed US-UK gene therapy company Orchard Therapeutics has raised $150m in a Series C financing just four months after acquiring GlaxoSmithKline’s portfolio of investigational and approved rare disease gene therapies. The financing was led by Deerfield Management, a leading US healthcare investor, and included more than […]
Phaunos Timber rejects Stafford’s Offer – the Chairman of Phaunos Timber (PTF) has sent a letter to Phaunos Shareholders, giving them an update on plans to wind up the company and to reject the cash offer made on 3rd July by Stafford Capital Partners. This is the latest communication from the Board of Phaunos in a long running saga, where […]
JPMorgan Brazil struggles in a politically-driven market – During JPMorgan Brazil (JPB)’s financial year to 30th April 2018, Brazil’s equity market experienced a highly volatile period mainly driven by political concerns. Performance The company recorded more modest sterling returns this year as the Brazilian currency, the Real significantly weakened against Sterling by some 17%. The total return on net assets was […]
Pantheon International has had a “milestone year” – In his introductory comment to Pantheon International (PIN)‘s full report for the twelve months to 31st May 2018, chairman Sir Laurie Magnus noted that the company had celebrated its 30 year anniversary, simplified its capital structure and entered the FTSE 250 index, in what he saw as a milestone […]
NextEnergy Solar adds 282 rooftop solar assets to its portfolio – NextEnergy Solar Fund (NESF) has added a further 1.15MW of capacity through the acquisition of two portfolios of roof top solar assets in the UK. This is the company’s second rooftop portfolio acquisition. The company has signed a share purchase agreement to acquire the two portfolios for a total investment […]
Regional REIT successfully raises £50 million in bond issue – In July, we reported Regional REIT (RGL)‘s plans to to issue bonds – click here to read that story The company has announced that it has successful raised £50 million and that the bonds have been admitted to trading on London Stock Exchange today (7th August 2018) The […]
Trust favourite Alnylam approaches key FDA decision Biotech trust stock favourite Alnylam Pharmaceuticals (Nasdaq:ALNY) should find out later this week whether the FDA will grant approval to its first product, Onpattro (patisiran), for hereditary transthyretin-mediated amyloidosis (or hATTR). In this case, unusually, there is relatively little concern that Onpattro may not receive US approval and the […]
IBT backed Regeneron teams up with Bluebird on T cell cancer therapies US top tier biotech Regeneron Pharmaceuticals (NASDAQ: REGN) is to make a $100m equity investment at a 59% premium in the gene therapy pioneer Bluebird Bio, as part of a newly established collaboration to develop and commercialise novel immune cell therapies for cancer. Regeneron is […]
Aberdeen Standard Logistics buys Dutch logistics warehouse – Aberdeen Standard European Logistics Income has signed an agreement to acquire a freehold logistics warehouse in Ede in the Netherlands for a net value of EUR26.5 million from David Hart Group. A fully CPI-indexed lease has been signed with Dutch retail and pharmacy operator Kruidvat (part of the A […]
